Insider Transactions in Q2 2021 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
David Mark Mc Clung EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,525
-8.18%
|
$138,300
$12.02 P/Share
|
|
Jun 11
2021
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+13.08%
|
-
|
|
Apr 25
2021
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-1.62%
|
$7,282
$11.71 P/Share
|
|
Apr 25
2021
|
Jason D. Fontenot SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
811
-1.28%
|
$8,921
$11.71 P/Share
|